Washington, DC – The Board of Pharmacy Specialties (BPS) has approved a practice analysis or role delineation study in solid organ transplantation for 2016. Conducting a role delineation study is a critical step in evaluating a proposed specialty.  The purpose of the role delineation study is to determine whether this practice area is based upon specialized knowledge of the pharmaceutical sciences, as well as specialized functions routinely performed by practitioners in the proposed specialty. BPS will appoint approximately 15 individuals with expertise in solid organ transplantation to conduct a practice analysis of this proposed specialty.

Individuals wishing to be considered for appointment to the Solid Organ Transplantation Role Delineation Study Taskforce should apply using the link below by 5 pm EST on June 1, 2016. BPS will make appointments by July 1, 2016 and the taskforce will convene in Washington, DC on August 26-27, 2016.

“While conducting a role delineation study does not assure that a call for petition to recognize a specialty will be issued, it does demonstrate the strong commitment of BPS to invest in the exploration of new specialties in furtherance of our mission to improve patient care by promoting the recognition and value of specialized training, knowledge, and skills in pharmacy and specialty board certification of pharmacists,” added BPS Immediate Past Chairman and President of the St. Louis College of Pharmacy, John A. Pieper, PharmD, FCCP.

The initial work of the practice analysis taskforce will be reviewed by an outside panel of subject matter experts and then validated via a survey administered to pharmacists practicing in the area. If the role delineation study yields information suggesting that solid organ transplantation should be considered as a specialty practice in pharmacy, BPS will then issue a call to the profession for a petition for specialty recognition of solid organ transplantation pharmacy practice.


About the Board of Pharmacy Specialties

The Board of Pharmacy Specialties (BPS) was established in 1976 as an autonomous division of the American Pharmacists Association (APhA).  The mission of the Board of Pharmacy Specialties is to improve patient care and increase awareness of the need for BPS Board Certified Pharmacists as integral members of multidisciplinary healthcare teams through recognition and promotion of specialized training, knowledge, and skills in pharmacy and specialty board certification and recertification of pharmacists throughout the world. Through the rigorous standards mandated by BPS board certification and recertification, the BPS board certified pharmacist stands out as the most qualified to accept today’s expanding professional expectations.  Today, almost 25,000 pharmacists are BPS board certified.


BPS CONTACT                                                                 

Steve Scarlata

BPS Social Media Coordinator

(202) 448-8721

Press Release PDF